Search research articles
Contact Us
Filters
Showing results (21-30 of 99) with videos related to
Page
of 10
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 12, 2003
Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis
John Dunlop, H Beal McIlvain, Yijin She, et al.
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
The Early Engagement Model in Product Development: Linking "Proof of Concept" to "Proof of Medical Value"
Sheikh Usman Iqbal, Tehseen Salimi, John Dunlop, et al.
Molecular Pharmacology
|
February 10, 2009
The four major N- and C-terminal splice variants of the excitatory amino acid transporter GLT-1 form cell surface homomeric and heteromeric assemblies
Eleanor Peacey, Christopher C J Miller, John Dunlop, et al.
Biochemical Pharmacology
|
October 13, 2010
Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research
Steven C Leiser, John Dunlop, Mark R Bowlby, et al.
Pharmacology & Therapeutics
|
April 9, 2009
A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits
Steven C Leiser, Mark R Bowlby, Thomas A Comery, et al.
Molecular and Cellular Neurosciences
|
October 6, 2007
mGlu4 potentiation of K(2P)2.1 is dependant on C-terminal dephosphorylation
Stuart M Cain, Helen J Meadows, John Dunlop, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 11, 2007
A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling
Kelly A Berg, John Dunlop, Teresa Sanchez, et al.
Analytical Biochemistry
|
July 8, 2008
Development of a scintillation proximity assay binding method for the human 5-hydroxytryptamine 6 receptor using intact cells
Tikva Carrick, Dianne Kowal, Stanley Nawoschik, et al.
Biochemical Pharmacology
|
December 13, 2005
Distinct functional profiles of aripiprazole and olanzapine at RNA edited human 5-HT2C receptor isoforms
Jean Y Zhang, Dianne M Kowal, Stanley P Nawoschik, et al.
Handbook of Experimental Pharmacology
|
October 3, 2012
5-HT(2C) agonists as therapeutics for the treatment of schizophrenia
Sharon Rosenzweig-Lipson, Thomas A Comery, Karen L Marquis, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 99) with videos related to
Sort By:
Page
of 10
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 12, 2003
Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis
John Dunlop, H Beal McIlvain, Yijin She, et al.
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
The Early Engagement Model in Product Development: Linking "Proof of Concept" to "Proof of Medical Value"
Sheikh Usman Iqbal, Tehseen Salimi, John Dunlop, et al.
Molecular Pharmacology
|
February 10, 2009
The four major N- and C-terminal splice variants of the excitatory amino acid transporter GLT-1 form cell surface homomeric and heteromeric assemblies
Eleanor Peacey, Christopher C J Miller, John Dunlop, et al.
Biochemical Pharmacology
|
October 13, 2010
Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research
Steven C Leiser, John Dunlop, Mark R Bowlby, et al.
Pharmacology & Therapeutics
|
April 9, 2009
A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits
Steven C Leiser, Mark R Bowlby, Thomas A Comery, et al.
Molecular and Cellular Neurosciences
|
October 6, 2007
mGlu4 potentiation of K(2P)2.1 is dependant on C-terminal dephosphorylation
Stuart M Cain, Helen J Meadows, John Dunlop, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 11, 2007
A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling
Kelly A Berg, John Dunlop, Teresa Sanchez, et al.
Analytical Biochemistry
|
July 8, 2008
Development of a scintillation proximity assay binding method for the human 5-hydroxytryptamine 6 receptor using intact cells
Tikva Carrick, Dianne Kowal, Stanley Nawoschik, et al.
Biochemical Pharmacology
|
December 13, 2005
Distinct functional profiles of aripiprazole and olanzapine at RNA edited human 5-HT2C receptor isoforms
Jean Y Zhang, Dianne M Kowal, Stanley P Nawoschik, et al.
Handbook of Experimental Pharmacology
|
October 3, 2012
5-HT(2C) agonists as therapeutics for the treatment of schizophrenia
Sharon Rosenzweig-Lipson, Thomas A Comery, Karen L Marquis, et al.
Page
of 10